US Stock Insider Trading | IBEX Discloses 7 Insider Transactions on February 12

2026-03-02 02:49:24

On February 12, 2026, IBEX (IBEX) disclosed seven insider transactions. Director Dechant Robert Thomas sold 19,000 shares on February 6, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 12, 2026	Director	Dechant Robert Thomas	February 6, 2026	Sell	19,000	34.98	664,200
February 12, 2026	Executive	Casteel Julie K	February 6, 2026	Sell	8,649	34.98	302,500
February 12, 2026	Executive	Trofimuk-O’Connor Christina Alice	February 6, 2026	Sell	2,176	34.98	76,100
February 12, 2026	Executive	Greenwald Taylor C	February 6, 2026	Sell	2,121	34.98	74,200
February 12, 2026	Executive	Dawson Bruce Neil	February 6, 2026	Sell	12,200	34.98	428,400
February 12, 2026	Executive	Afdahl David Martin	February 6, 2026	Sell	13,900	34.98	486,800
February 12, 2026	Executive	Darwal Michael Joseph	February 6, 2026	Sell	1,660	34.98	58,100
February 11, 2026	Executive	Inson Paul Joseph	February 6, 2026	Sell	2,627	34.98	91,900
December 30, 2025	Director	Ballou-Aares Daniella	December 30, 2025	Buy	2,066	19.00	39,300
October 2, 2025	Executive	Dawson Bruce Neil	October 2, 2025	Sell	959	39.58	38,000

[Company Information]

IBEX Limited was incorporated as an exempted limited liability company under Bermuda law on February 28, 2017. The company is a leading global CX provider, offering solutions to help well-known brands interact more effectively with their customers worldwide. Through its integrated Customer Lifecycle Experience (“CLX”) platform, the company provides solutions covering the entire customer lifecycle, ranging from comprehensive integrated products to customized solutions tailored to specific customer needs.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.